With Pfizer’s Xtandi sales slowing, analysts question $14B Medivation price

3rd May 2017 Uncategorised 0

With Pfizer’s Xtandi sales slowing, analysts question $14B Medivation price
chelfand
Wed, 05/03/2017 – 11:19




More: With Pfizer’s Xtandi sales slowing, analysts question B Medivation price
Source: fierce